The Dow Jones closed lower by more than 300 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
OPKO Health
- The Trade: OPKO Health, Inc. OPK CEO and Chairman Frost Gamma Investments Trust acquired a total of 75,000 shares an average price of $1.75. To acquire these shares, it cost around $131,260.
- What’s Happening: OPKO Health posted better-than-expected quarterly results.
- What OPKO Health Does: OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs.
Vapotherm
- The Trade: Vapotherm, Inc. VAPO President and CEO Joseph Army acquired a total of 300,000 shares at an average price of $0.40. The insider spent around $118,864.
- What’s Happening: Vapotherm posted a narrower-than-expected second-quarter loss.
- What Vapotherm Does: Vapotherm Inc is a medical technology company based in the United States. It is mainly engaged in the development and commercialization of its proprietary Hi-VNI technology products that are used to treat patients of all ages suffering from respiratory distress.
MarketWise
- The Trade: MarketWise, Inc. MKTW Director Glenn Tongue acquired a total of 6,800 shares at an average price of $1.71. To acquire these shares, it cost around $11,628. The company’s CEO also bought 19,000 shares of the company.
- What’s Happening: Marketwise posted weaker-than-expected quarterly sales.
- What MarketWise Does: Marketwise Inc is a multi-brand subscription services platform providing premium financial research, software, education, and tools for investors. Its products are built for high-value financial research, education, actionable investment ideas, and investment software.
Check This Out: Investor Sentiment Declines Further After Weak China Data
Don’t forget to check out our premarket coverage here
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.